These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1191630)

  • 1. Alkyl isocyanates as active site-specific reagents for serine proteases. Location of alkyl binding site in chymotrypsin by X-ray diffraction.
    Brown WE
    Biochemistry; 1975 Nov; 14(23):5079-84. PubMed ID: 1191630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkyl isocyanates as active site-specific inhibitors of chymotrypsin and elastase.
    Brown WE; Wold F
    Science; 1971 Nov; 174(4009):608-10. PubMed ID: 5114826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkyl isocyanates as active-site-specific reagents for serine proteases. Reaction properties.
    Brown WE; Wold F
    Biochemistry; 1973 Feb; 12(5):828-34. PubMed ID: 4346923
    [No Abstract]   [Full Text] [Related]  

  • 4. X-ray diffraction analysis of the inactivation of chymotrypsin by 3-benzyl-6-chloro-2-pyrone.
    Ringe D; Mottonen JM; Gelb MH; Abeles RH
    Biochemistry; 1986 Sep; 25(19):5633-8. PubMed ID: 3096374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of chymotrypsin by 5-benzyl-6-chloro-2-pyrone: 13C NMR and X-ray diffraction analyses of the inactivator-enzyme complex.
    Ringe D; Seaton BA; Gelb MH; Abeles RH
    Biochemistry; 1985 Jan; 24(1):64-8. PubMed ID: 3994973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkyl isocyanates as active-site-specific reagents for serine proteases. Identification of the active-site serine as the site of reaction.
    Brown WE; Wold F
    Biochemistry; 1973 Feb; 12(5):835-40. PubMed ID: 4686800
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure of bovine trypsinogen at 1.9 A resolution.
    Kossiakoff AA; Chambers JL; Kay LM; Stroud RM
    Biochemistry; 1977 Feb; 16(4):654-64. PubMed ID: 556951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Babson JR; Reed DJ; Sinkey MA
    Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active site dynamics of acyl-chymotrypsin.
    Nakagawa S; Yu HA; Karplus M; Umeyama H
    Proteins; 1993 Jun; 16(2):172-94. PubMed ID: 8332606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A detailed structural comparison between the charge relay system in chymotrypsinogen and in alpha-chymotrypsin.
    Birktoft JJ; Kraut J; Freer ST
    Biochemistry; 1976 Oct; 15(20):4481-5. PubMed ID: 974071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and conformational properties of a synthetic cyclic peptide for the active site of alpha-chymotrypsin.
    Schultz RM; Huff JP; Anagnostaras P; Olsher U; Blout ER
    Int J Pept Protein Res; 1982 May; 19(5):454-69. PubMed ID: 7118415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of chloromethyl ketone substrate analogues to crystalline papain.
    Drenth J; Kalk KH; Swen HM
    Biochemistry; 1976 Aug; 15(17):3731-8. PubMed ID: 952885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct observation of the titration of substrate carbonyl groups in the active site of alpha-chymotrypsin by resonance Raman spectroscopy.
    Tonge PJ; Carey PR
    Biochemistry; 1989 Aug; 28(16):6701-9. PubMed ID: 2790025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of native peptides as potent inhibitors of enzymes. Crystal structure of the complex formed between treated bovine alpha-chymotrypsin and an autocatalytically produced fragment, IIe-Val-Asn-Gly-Glu-Glu-Ala-Val-Pro-Gly-Ser-Trp-Pro-Trp, at 2.2 angstroms resolution.
    Singh N; Jabeen T; Sharma S; Roy I; Gupta MN; Bilgrami S; Somvanshi RK; Dey S; Perbandt M; Betzel C; Srinivasan A; Singh TP
    FEBS J; 2005 Jan; 272(2):562-72. PubMed ID: 15654893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of chymotrypsin with the specific cyanate reagent N-acetyl-p-cyanato-l-phenylalanine ethyl ester.
    Powers JC; Tuhy PM; Witter F
    Biochim Biophys Acta; 1976 Sep; 445(2):426-36. PubMed ID: 953038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical and crystallographic study of carbamyl-chymotrypsin A.
    Robillard GT; Powers JC; Wilcox PE
    Biochemistry; 1972 May; 11(10):1773-84. PubMed ID: 5063532
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of functionality of alpha-chymotrypsin. An alternate binding mode in the substrate specificity site.
    Tulinsky A; Mavridis I; Mann RF
    J Biol Chem; 1978 Feb; 253(4):1074-8. PubMed ID: 624719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters.
    Bone R; Sampson NS; Bartlett PA; Agard DA
    Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of catalytic activity of enzymes by heating in anhydrous organic solvents: 3D structure of a modified serine proteinase at high resolution.
    Sharma S; Tyagi R; Gupta MN; Singh TP
    Indian J Biochem Biophys; 2001; 38(1-2):34-41. PubMed ID: 11563328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is gamma-chymotrypsin a tetrapeptide acyl-enzyme adduct of alpha-chymotrypsin?
    Dixon MM; Matthews BW
    Biochemistry; 1989 Aug; 28(17):7033-8. PubMed ID: 2819046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.